WAVE Life Sciences Ltd.
WVE
$5.65
$0.173.10%
Weiss Ratings | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.49 | |||
Price History | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -25.36% | |||
30-Day Total Return | -46.55% | |||
60-Day Total Return | -50.74% | |||
90-Day Total Return | -62.58% | |||
Year to Date Total Return | -57.57% | |||
1-Year Total Return | -5.83% | |||
2-Year Total Return | 20.47% | |||
3-Year Total Return | 157.99% | |||
5-Year Total Return | -25.95% | |||
52-Week High % Change | -67.25% | |||
52-Week Low % Change | 28.94% | |||
Price | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $16.74 | |||
52-Week Low Price | $4.25 | |||
52-Week Low Price (Date) | Jun 27, 2024 | |||
52-Week High Price (Date) | Nov 11, 2024 | |||
Valuation | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 841.10M | |||
Enterprise Value | 572.30M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.80 | |||
Earnings Per Share Growth | 43.46% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 8.72 | |||
Price/Book (Q) | 4.00 | |||
Enterprise Value/Revenue (TTM) | 5.28 | |||
Price | $5.65 | |||
Enterprise Value/EBITDA (TTM) | -5.37 | |||
Enterprise Value/EBIT | -5.18 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 172.29M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 65 6236 3388 | |||
Address | -- | |||
Website | wavelifesciences.com | |||
Country | Singapore | |||
Year Founded | 2012 | |||
Profitability | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -101.93% | |||
Profit Margin | -89.57% | |||
Management Effectiveness | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -22.00% | |||
Return on Equity | -- | |||
Income Statement | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 108.30M | |||
Total Revenue (TTM) | 108.30M | |||
Revenue Per Share | $0.63 | |||
Gross Profit (TTM) | -51.38M | |||
EBITDA (TTM) | -106.51M | |||
EBIT (TTM) | -110.40M | |||
Net Income (TTM) | -97.01M | |||
Net Income Avl. to Common (TTM) | -97.01M | |||
Total Revenue Growth (Q YOY) | 188.23% | |||
Earnings Growth (Q YOY) | 279.95% | |||
EPS Diluted (TTM) | -0.80 | |||
EPS Diluted Growth (Q YOY) | 212.24% | |||
Balance Sheet | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 302.08M | |||
Cash Per Share (Q) | $1.75 | |||
Total Current Assets (Q) | 320.39M | |||
Total Preferred Equity (Q) | 7.87 | |||
Total Equity (Q) | 217.39M | |||
Current Ratio (Q) | 2.888 | |||
Book Value Per Share (Q) | $1.37 | |||
Total Assets (Q) | 352.21M | |||
Total Current Liabilities (Q) | 110.95M | |||
Total Debt (Q) | 25.40M | |||
Total Liabilities (Q) | 134.82M | |||
Total Common Equity (Q) | 209.52M | |||
Cash Flow | WVE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -938.00K | |||
Cash from Financing (TTM) | 253.89M | |||
Net Change in Cash (TTM) | 101.79M | |||
Levered Free Cash Flow (TTM) | -114.86M | |||
Cash from Operations (TTM) | -151.03M | |||